NFKB1 and colorectal carcinoma: La et al. (2019) mentioned that EGCG showed anticancer effect by augmenting the sensitivity of CRC cell lines (HCT‐116, DLD1) to 5‐FU via inhibited GRP78 expression, activated NF‐κB, and improved miR‐155‐5p level.